Skip to main content
. 2021 Mar 19;100(11):e24827. doi: 10.1097/MD.0000000000024827

Table 1.

The Statistical significance between each comparison (Expression level of GINS subunits and individual cancer stages).

Comparison GINS1 GINS2 GINS3 GINS4
Normal VS Stage1 <1E−12 <1E−12 1.17E−04 1.97E−12
Normal VS Stage2 1.62E−12 1.62E−12 1.62E−12 <1E−12
Normal VS Stage3 1.62E−12 1.62E−12 9.07E−10 <1E−12
Normal VS Stage4 1.72E−05 3.03E−04 5.75E−02 8.40E−03
Stage1 VS Stage2 1.41E−02 7.82E−05 1.02E−03 6.30E−03
Stage1 VS Stage3 6.26E−02 1.36E−03 1.10E−01 2.42E−01
Stage1 VS Stage4 8.20E−01 9.19E−02 9.22E−01 9.12E−01
Stage2 VS Stage3 9.31E−01 8.54E−01 1.25E−01 1.82E−01
Stage2 VS Stage4 4.94E−01 3.89E−01 1.33E−01 4.17E−01
Stage3 VS Stage4 2.29E−01 4.78E−01 5.69E−01 7.10E−01